Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1

PHASE3CompletedINTERVENTIONAL
Enrollment

516

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Opioid-Related Disorders
Interventions
DRUG

Buprenorphine

Trial Locations (11)

10010

New York VA Medical Center, New York

11004

LI Jewish Health System, Glen Oaks

23505

Norfolk CSB, Norfolk

27610

South Light-Wakeview Clinic, Raleigh

28412

Coastal Horizons Center, Inc., Wilmington

80204

Addiction Research & Treatment Services (ARTS), Denver

Denver Health & Hospitals Authority, Denver

97214

CODA, Portland

98201

Providence Behavioral Health Services, Everett

06120

Hartford Dispensary, Hartford

06705

Connecticut Counseling Centers, Waterbury

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT00078117 - Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1 | Biotech Hunter | Biotech Hunter